Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 165
Selected: 0
NCT IDTitle
NCT01566877A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers
NCT00067041Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft
NCT00494533Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension
NCT06388421DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT04287478Bacteriophage Therapy in Patients With Urinary Tract Infections
NCT04411680Study of Sargramostim in Patients With COVID-19
NCT06477640Home Rehabilitation Improves Cardiac Effort in Pulmonary Arterial Hypertension
NCT02074449Study Of Right Ventricular Performance In PAH Patients Treated With Rapid Dose Treprostinil (Remodulin)
NCT01353040Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus
NCT03497689EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension
NCT00705133Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension
NCT05943535Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
NCT04865393Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function
NCT02261883Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
NCT06964009DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer
NCT01934582A Pharmacokinetic Substudy of the TDE-PH-304 Protocol
NCT00848107Open-Label Study of Oral Treprostinil in Digital Ulcers
NCT02999906Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension
NCT00741819Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects
NCT02279745Long-term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension
NCT04707664Sargramostim Use in COVID-19 to Recover Patient Health
NCT01273922Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida
NCT01980979Efficacy of Remodulin in Adults With Congenital Heart Disease (ACHD) and Pulmonary Hypertension
NCT01104870A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension
NCT01996254Electrical Stimulation for the Treatment of Post-Amputation Pain Using the SPRINT System
NCT04005469Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
NCT06911632Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
NCT00963001Effect of Food on the Pharmacokinetics of Oral Treprostinil
NCT00508586PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer
NCT04870333PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V
NCT03833323Implantable System for Remodulin Post-Approval Study
NCT04712266A Trial to Investigate Hyperglycemic and Hypoglycemic Excursions in Subjects With Type 1 Diabetes
NCT00848939Pharmacokinetics of Oral Treprostinil in Patients With Systemic Sclerosis
NCT02583789Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon
NCT05776225Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
NCT05564637A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension
NCT04084678Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH Subjects
NCT00775463Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine
NCT00058929A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertension
NCT01593072A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers
NCT05340426Porcine Kidney Xenotransplantation in Patients With End-Stage Kidney Disease
NCT02663895Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic Sclerosis
NCT03047369The Myelin Disorders Biorepository Project
NCT01799473Tyvaso Dosing and Titration Evaluation: TyTRATE Registry
NCT04850105A Non-interventional Cohort Safety Study of Patients With hATTR-PN
NCT03037580Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
NCT01477333Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®
NCT01042158A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
NCT06450041NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
NCT02882126An Open Label Extension Study to Evaluate the Safety of Continued Therapy of Subcutanous Remodulin® in Pulmonary Arterial Hypertension